Skip to main content
ConductScienceScienceDex

Kevin W Garey

NIH Rank #13733
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8698339Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • BIOLOGY
  • SOCIAL SCIENCES

NIH Funding · FY2024

Linked Award Amount
$1.1M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#13,733
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Kevin W Garey. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Kevin W Garey as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI139261-06R01
    Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infection.
    Texas A&M Health Science Center
    $768.1K
    award amount
  • 3R01AI139261-06S1R01
    Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infection.
    Texas A&M Health Science Center
    $183.8K
    award amount
  • 1R03AI178015-01A1R03
    Vancomycin Susceptibility Measures to Evaluate C. difficile infection Outcomes
    University of Houston
    $77.9K
    award amount
  • 3R01AI139261-06S2R01
    Diversity Supplement: Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infection
    Texas A&M Health Science Center
    $52.4K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Kevin W Garey as a PI.

Texas A&M Health Science Center
TX
$1M
3 grants
University of Houston
TX
$77.9K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Texas A&M Health Science Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  5. 2025
    R01 Grant Holder
  6. 2026
    $2M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Kevin W Garey.

Julian G Hurdle
Texas A&M Health Science Center
5
shared awards

Explore further

Find collaborators for Kevin W Garey

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →